Moncyte is the next level decision making tool to revolutionize the treatment of high cholesterol patients and save live
Moncyte is a next level decision making tool generating new type of data from a blood sample that can revolutionize how patients with high cholesterol are treated to prevent cardiovascular disease. Our unique technology is able to perform an in-depth analysis of cellular mechanisms shedding light on why some people respond differently to cholesterol-lowering drugs, opening new ways for personalized medicine for doctors and patients, and generating unique data points for research and big Pharma. Currently finalizing spinout process from the University of Helsinki, establishing the company, open for collaboration and finalizing seed funding round in Q1 2024.
Check out our rockstar contributors community and meet the people behind Sesamers!
Sesamers is the insiders advantage to professional events.
By category
By country
Stay at the forefront with our curated guide to the best upcoming Tech events.